4//SEC Filing
Shirvan Mitchell 4
Accession 0001178913-18-000730
CIK 0001606645other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:15 PM ET
Size
7.7 KB
Accession
0001178913-18-000730
Insider Transaction Report
Form 4
Shirvan Mitchell
VP Innovation & Discovery
Transactions
- Award
Ordinary Shares
2018-02-27+5,000→ 24,980 total - Award
Options
2018-02-27$6.40/sh+15,000$96,000→ 15,000 totalExercise: $6.40Exp: 2028-02-27→ Ordinary Shares (15,000 underlying)
Footnotes (4)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a period of four years (25% on February 27, 2019 and 6.25% every three months thereafter) ending February 27, 2022.
- [F3]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F4]The ordinary shares underlying these options vest over a period of four years (25% on February 27, 2019 and 6.25% every three months thereafter) ending February 27, 2022.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727789
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:15 PM ET
- Size
- 7.7 KB